Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Jack H. Landmann Clear advanced filters
  • One of three back-to-back papers to show that dosage of BACH2 can modulate T cell differentiation and function and how we might apply this to enhance CAR T cell therapies for cancer.

    • Tien-Ching Chang
    • Amanda Heard
    • Nathan Singh
    Research
    Nature Immunology
    P: 1-12
  • Loss of surface CD19 expression by leukemic cells leads to resistance and relapse to CD19-targeted CAR-T therapies. Here the authors show that loss of SPPL3 in malignant B cells results in hyperglycosylation of CD19.

    • Amanda Heard
    • Jack H. Landmann
    • Nathan Singh
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-11